Due to the lack of summary of the clinical manifestation, risk factors, associated ALPL variants, and treatment, we conducted this systematic review with the goal to summarize the characteristics of all reported patients with HPP who sustained AFF. This evidence concerns the gene ALPL and hypophosphatasia.